BLAU FARMACÊUTICA S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.47 BRL | +1.29% |
|
-3.86% | -36.20% |
| May. 07 | Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 20 | Transcript : Blau Farmacêutica S.A., Q4 2023 Earnings Call, Mar 20, 2024 |
Evolution of the average Target Price on Blau Farmacêutica S.A.
Price target over the last 5 years
History of analyst recommendation changes
8821fc6446ea28c1c.kFlXMiE6xcsnjMMHeFncIjMoQ35oWaeiDNNO1sxjxx4.5yNuXHBbq5J04KhkMW-YRXgcKB8iEP3BSIcesJ4IvSjjHgFYGHGImmX5mg~8845023da4d43619997488131cd05d7e
Analysts' Consensus
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
7
Last Close Price
10.47
BRL
Average target price
13.57
BRL
Spread / Average Target
+29.62%
High Price Target
18
BRL
Spread / Highest target
+71.92%
Low Price Target
10
BRL
Spread / Lowest Target
-4.49%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- BLAU3 Stock
- Consensus Blau Farmacêutica S.A.
